Listen in as a doctor and a person with diabetes chat about new diabetes science. Cohosts Neil S. Skolnik, MD, professor of family and consumer medicine at Temple University School of Medicine and associate director of the family medicine residency program at Abington Memorial Hospital, and Kelly Rawlings, PWD, editorial director of Diabetes Forecast magazine, discuss highlights from the American Diabetes Association's professional scientific journals.
Episode 36: T2 Medication Hypo Risk, Diabetes and Your Brain
Compared with short-acting sulfonylureas—a common treatment for type 2 diabetes—long-acting sulfonylureas have a higher risk of low blood glucose. Then, are you forgetful or losing concentration at times? Find out how high blood glucose can affect your thinking.
What to know and do to prepare for your diabetes care during a weather emergency or other disruption.
The first study we’ll discuss looks at some of the challenges to taking medication as directed. The second is an update of blood pressure management recommendations for people with diabetes.
In today’s busy world, information can come at you from so many sources—news reports, social media, magazine articles. And advertisements. When it comes to ads for drugs and other medical products, here’s what to know about reliable information, what can you trust, and why.
Episode 32: July 2017
Brand-new information shared at the American Diabetes Association’s recent Scientific Sessions about SGLT2-inhibitors and unprecedented protection for the heart. And a study that investigated whether monitoring blood glucose makes a difference in type 2 diabetes.
Episode 31: Type 2 Diabetes Drugs—Part 3
The final episode of our series about type 2 diabetes medications focuses on an injectable medication that’s been around the longest—since the early 1920s in fact. That medication is insulin, available today in various formulations that are used once daily or multiple times a day, depending on what your body needs.